advertisement
11.13.4 Betablocker and prostaglandin (5)
Showing records 1 to 5
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin49015 Comparison of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations on Diurnal Intraocular Pressure Control in Primary Open-Angle Glaucoma
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 381-386
49217 Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
Nakakura S; Tabuchi H; Baba Y; Maruiwa F; Ando N; Kanamoto T; Kiuchi Y
Clinical Ophthalmology 2012; 6: 369-375
48637 Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 581-587
49097 Overview of the BAK-free travoprost /timolol BAK-free fixed combination
Konstas AG; Quaranta L; Realini T
Expert Opinion in Pharmacotherapy 2012; 13: 757-766
49078 Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs
Inoue K; Setogawa A; Higa R; Moriyama R; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 231-235
